AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47
ROLE OF ENDOTHELIN AND NITRIC-OXIDE IMBALANCE IN THE PATHOGENESIS OF HYPOXIA-INDUCED ARTERIAL-HYPERTENSION
Authors: NI ZM BEMANIAN S KIVLIGHN SD VAZIRI ND
Citation: Zm. Ni et al., ROLE OF ENDOTHELIN AND NITRIC-OXIDE IMBALANCE IN THE PATHOGENESIS OF HYPOXIA-INDUCED ARTERIAL-HYPERTENSION, Kidney international, 54(1), 1998, pp. 188-192
RENAL PROTECTION BY A DUAL ETA ETB ENDOTHELIN ANTAGONIST, L-754,142, AFTER AORTIC CROSS-CLAMPING IN THE DOG/
Authors: KRAUSE SM WALSH TF GREENLEE WJ RANAEI R WILLIAMS DL KIVLIGHN SD
Citation: Sm. Krause et al., RENAL PROTECTION BY A DUAL ETA ETB ENDOTHELIN ANTAGONIST, L-754,142, AFTER AORTIC CROSS-CLAMPING IN THE DOG/, Journal of the American Society of Nephrology, 8(7), 1997, pp. 1061-1071
LACK OF BENEFICIAL-EFFECTS OF GROWTH-HORMONE TREATMENT IN CONSCIOUS DOGS DURING THE DEVELOPMENT OF CONGESTIVE-HEART-FAILURE
Authors: SHEN YT WOLTMANN RF APPLEBY SD VOLKSDORF SR PRAHALADA S KRAUSE SM KIVLIGHN SD JOHNSON RG SIEGL PK LYNCH JJ
Citation: Yt. Shen et al., LACK OF BENEFICIAL-EFFECTS OF GROWTH-HORMONE TREATMENT IN CONSCIOUS DOGS DURING THE DEVELOPMENT OF CONGESTIVE-HEART-FAILURE, Circulation, 96(8), 1997, pp. 2768-2768
A NEW METHOD OF MEASURING RENAL-FUNCTION IN CONSCIOUS RATS WITHOUT THE USE OF RADIOISOTOPES
Authors: GABEL RA RANAEI RA KIVLIGHN SD
Citation: Ra. Gabel et al., A NEW METHOD OF MEASURING RENAL-FUNCTION IN CONSCIOUS RATS WITHOUT THE USE OF RADIOISOTOPES, Journal of pharmacological and toxicological methods, 36(4), 1996, pp. 189-197
L-162,389 - A POTENT ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONISTWITH BALANCED AFFINITY TO BOTH AT(1) AND AT(2) RECEPTOR SUBTYPES
Authors: RIVERO RA KEVIN NJ KIVLIGHN SD ZINGARO GJ CHANG RS GREENLEE WJ
Citation: Ra. Rivero et al., L-162,389 - A POTENT ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONISTWITH BALANCED AFFINITY TO BOTH AT(1) AND AT(2) RECEPTOR SUBTYPES, Bioorganic & medicinal chemistry letters, 6(3), 1996, pp. 307-310
IN-VIVO PHARMACOLOGY OF L-159,913, A NEW HIGHLY POTENT AND SELECTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST
Authors: GABEL RA KIVLIGHN SD ZINGARO GJ SCHORN TW SCHAFFER LW ASHTON WT CHANG LL FLANAGAN K GREENLEE WJ SIEGL PKS
Citation: Ra. Gabel et al., IN-VIVO PHARMACOLOGY OF L-159,913, A NEW HIGHLY POTENT AND SELECTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST, Clinical and experimental hypertension, 17(6), 1995, pp. 931-953
L-754,142, AN ENDOTHELIN (ET) RECEPTOR ANTAGONIST, REDUCES RADIOCONTRAST INDUCED DECREASES IN RENAL-FUNCTION
Authors: GABEL RA KIVLIGHN SD KRAUSE SM RANAEI R WILLIAMS DL WALSH TF GREENLEE WJ SIEGL PKS
Citation: Ra. Gabel et al., L-754,142, AN ENDOTHELIN (ET) RECEPTOR ANTAGONIST, REDUCES RADIOCONTRAST INDUCED DECREASES IN RENAL-FUNCTION, Journal of the American Society of Nephrology, 6(3), 1995, pp. 978-978
TREATMENT WITH AN ENDOTHELIN (ET) ANTAGONIST PROVIDES A MORE RAPID RETURN TO NORMAL RENAL-FUNCTION FOLLOWING ISCHEMIA-INDUCED ACUTE-RENAL-FAILURE (ARF) IN THE RAT
Authors: KIVLIGHN SD GABEL RA KRAUSE SM RANAEI R WILLIAMS DL WALSH TF GREENLEE WJ SIEGL PKS
Citation: Sd. Kivlighn et al., TREATMENT WITH AN ENDOTHELIN (ET) ANTAGONIST PROVIDES A MORE RAPID RETURN TO NORMAL RENAL-FUNCTION FOLLOWING ISCHEMIA-INDUCED ACUTE-RENAL-FAILURE (ARF) IN THE RAT, Journal of the American Society of Nephrology, 6(3), 1995, pp. 982-982
THE ENDOTHELIN ANTAGONIST, L-754,142, PROTECTS RENAL-FUNCTION FOLLOWING 60 MINUTES OF AORTIC CROSS-CLAMPING (ACC) IN THE DOG
Authors: KRAUSE SM WALSH TF GREENLEE WJ RANAEI R KIVLIGHN SD
Citation: Sm. Krause et al., THE ENDOTHELIN ANTAGONIST, L-754,142, PROTECTS RENAL-FUNCTION FOLLOWING 60 MINUTES OF AORTIC CROSS-CLAMPING (ACC) IN THE DOG, Journal of the American Society of Nephrology, 6(3), 1995, pp. 983-983
A POSSIBLE ROLE FOR THE ENDOTHELIN-B (ET(B)) RECEPTOR IN ACUTE CYCLOSPORINE-A (CSA) INDUCED NEPHROTOXICITY
Authors: KIVLIGHN SD GABEL R WILLIAMS DL WALSH TF GREENLEE WJ SIEGL PKS
Citation: Sd. Kivlighn et al., A POSSIBLE ROLE FOR THE ENDOTHELIN-B (ET(B)) RECEPTOR IN ACUTE CYCLOSPORINE-A (CSA) INDUCED NEPHROTOXICITY, Journal of the American Society of Nephrology, 6(3), 1995, pp. 999-999
AT(1) SELECTIVE ANGIOTENSIN-II ANTAGONISTS WITH PHENOXYPHENYLACETIC ACID AS A BIPHENYL REPLACEMENT .1.
Authors: FITCH KJ WALSH TF PATCHETT AA CHANG RSL SIEGL PKS FAUST KA CHEN TB LOTTI VJ KIVLIGHN SD ZINGARO GJ GREENLEE WJ
Citation: Kj. Fitch et al., AT(1) SELECTIVE ANGIOTENSIN-II ANTAGONISTS WITH PHENOXYPHENYLACETIC ACID AS A BIPHENYL REPLACEMENT .1., Bioorganic & medicinal chemistry letters, 5(2), 1995, pp. 155-158
THE SAR OF -2-PROPYL-3-[(2'-TETRAZOL-5-YL)BIPHEN-4-YL)METHYL] QUINAZOLINONES AS BALANCED AFFINITY ANTAGONISTS OF THE HUMAN AT(1) AND AT(2) RECEPTORS
Authors: DELASZLO SE CHANG RS CHEN TB FAUST KA GREENLEE WJ KIVLIGHN SD LOTTI VJ OMALLEY SS SCHORN TW SIEGL PK TRAN J ZINGARO GJ
Citation: Se. Delaszlo et al., THE SAR OF -2-PROPYL-3-[(2'-TETRAZOL-5-YL)BIPHEN-4-YL)METHYL] QUINAZOLINONES AS BALANCED AFFINITY ANTAGONISTS OF THE HUMAN AT(1) AND AT(2) RECEPTORS, Bioorganic & medicinal chemistry letters, 5(13), 1995, pp. 1359-1364
ALPHA-PHENOXYPHENYLACETIC ACID-DERIVED ANGIOTENSIN-II ANTAGONISTS WITH LOW NANOMOLAR AT(1) AT(2) RECEPTOR SUBTYPE AFFINITY .2./
Authors: WALSH TF KIVLIGHN SD ZINGARO GJ FITCH KJ CHANG RSL FAUST KA CHEN TB LOTTI VJ SIEGL PKS PATCHETT AA GREENLEE WJ
Citation: Tf. Walsh et al., ALPHA-PHENOXYPHENYLACETIC ACID-DERIVED ANGIOTENSIN-II ANTAGONISTS WITH LOW NANOMOLAR AT(1) AT(2) RECEPTOR SUBTYPE AFFINITY .2./, Bioorganic & medicinal chemistry letters, 5(11), 1995, pp. 1151-1154
IN-VIVO PHARMACOLOGY OF A NOVEL AT(1) SELECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST, MK-996
Authors: KIVLIGHN SD ZINGARO GJ GABEL RA BROTEN TP SCHORN TW SCHAFFER LW NAYLOR EM CHAKRAVARTY PK PATCHETT AA GREENLEE WJ SIEGL PKS
Citation: Sd. Kivlighn et al., IN-VIVO PHARMACOLOGY OF A NOVEL AT(1) SELECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST, MK-996, American journal of hypertension, 8(1), 1995, pp. 58-66
DISCOVERY OF L-162,313 - A NONPEPTIDE THAT MIMICS THE BIOLOGICAL ACTIONS OF ANGIOTENSIN-II
Authors: KIVLIGHN SD HUCKLE WR ZINGARO GJ RIVERO RA LOTTI VJ CHANG RSL SCHORN TW KEVIN N JOHNSON RG GREENLEE WJ SIEGL PKS
Citation: Sd. Kivlighn et al., DISCOVERY OF L-162,313 - A NONPEPTIDE THAT MIMICS THE BIOLOGICAL ACTIONS OF ANGIOTENSIN-II, American journal of physiology. Regulatory, integrative and comparative physiology, 37(3), 1995, pp. 820-823
PHARMACOLOGY OF LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN ANIMAL-MODELS OF HYPERTENSION
Authors: SIEGL PKS KIVLIGHN SD BROTEN TP
Citation: Pks. Siegl et al., PHARMACOLOGY OF LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, IN ANIMAL-MODELS OF HYPERTENSION, Journal of hypertension, 13, 1995, pp. 15-21
AT(1) AT(2)-BALANCED ANGIOTENSIN-II ANTAGONISTS/
Authors: ASHTON WT CHANG LL FLANAGAN KL MANTLO NB ONDEYKA DL KIM D DELASZLO SE GLINKA TW RIVERO RA KEVIN NJ CHANG RSL SIEGL PKS KIVLIGHN SD GREENLEE WJ
Citation: Wt. Ashton et al., AT(1) AT(2)-BALANCED ANGIOTENSIN-II ANTAGONISTS/, European journal of medicinal chemistry, 30, 1995, pp. 255-266
RESPONSES TO A NONPEPTIDE ANGIOTENSIN RECEPTOR AGONIST, L-163491, IN THE FELINE PULMONARY VASCULAR BED
Authors: KAYE AD NOSSAMAN BD MARGOLIS MA IBRAHIM IN KIVLIGHN SD SMITH DE KADOWITZ PJ
Citation: Ad. Kaye et al., RESPONSES TO A NONPEPTIDE ANGIOTENSIN RECEPTOR AGONIST, L-163491, IN THE FELINE PULMONARY VASCULAR BED, Life sciences, 57(20), 1995, pp. 301-305
PHARMACOLOGY OF L-754,142, A HIGHLY POTENT, ORALLY-ACTIVE, NONPEPTIDYL ENDOTHELIN ANTAGONIST
Authors: WILLIAMS DL MURPHY KL NOLAN NA OBRIEN JA PETTIBONE DJ KIVLIGHN SD KRAUSE SM LIS EV ZINGARO GJ GABEL RA CLAYTON FC SIEGL PKS ZHANG K NAUE J VYAS K WALSH TF FITCH KJ CHAKRAVARTY PK GREENLEE WJ CLINESCHMIDT BV
Citation: Dl. Williams et al., PHARMACOLOGY OF L-754,142, A HIGHLY POTENT, ORALLY-ACTIVE, NONPEPTIDYL ENDOTHELIN ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 275(3), 1995, pp. 1518-1526
POTENT AND ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONISTS WITH EQUAL AFFINITY FOR HUMAN AT(1) AND AT(2) SUBTYPES
Authors: CHANG LL ASHTON WT FLANAGAN KL CHEN TB OMALLEY SS ZINGARO GJ KIVLIGHN SD SIEGL PKS LOTTI VJ CHANG RSL GREENLEE WJ
Citation: Ll. Chang et al., POTENT AND ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONISTS WITH EQUAL AFFINITY FOR HUMAN AT(1) AND AT(2) SUBTYPES, Journal of medicinal chemistry, 38(19), 1995, pp. 3741-3758
IN-VITRO PHARMACOLOGY OF AN ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST WITH BALANCED AFFINITY FOR AT(2) RECEPTORS
Authors: CHANG RSL LOTTI VJ CHEN TB OMALLEY SS BENDESKY RJ KLING PJ KIVLIGHN SD SIEGL PKS ONDEYKA D GREENLEE WJ MANTLO NB
Citation: Rsl. Chang et al., IN-VITRO PHARMACOLOGY OF AN ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST WITH BALANCED AFFINITY FOR AT(2) RECEPTORS, European journal of pharmacology, 294(2-3), 1995, pp. 429-437
IN-VIVO PHARMACOLOGY OF AN ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST WITHBALANCED AFFINITY FOR ANGIOTENSIN AT(2) RECEPTORS
Authors: KIVLIGHN SD ZINGARO GJ GABEL RA BROTEN TP CHANG RSL ONDEYKA DL MANTLO NB GIBSON RE GREENLEE WJ SIEGL PKS
Citation: Sd. Kivlighn et al., IN-VIVO PHARMACOLOGY OF AN ANGIOTENSIN AT(1) RECEPTOR ANTAGONIST WITHBALANCED AFFINITY FOR ANGIOTENSIN AT(2) RECEPTORS, European journal of pharmacology, 294(2-3), 1995, pp. 439-450
RENAL PROTECTION BY AN ENDOTHELIN ANTAGONIST, L-754,142, FOLLOWING AORTIC CROSS-CRAMPING IN THE DOG
Authors: KRAUSE SM WALSH TF GREENLEE WJ RANAEI R KIVLIGHN SD
Citation: Sm. Krause et al., RENAL PROTECTION BY AN ENDOTHELIN ANTAGONIST, L-754,142, FOLLOWING AORTIC CROSS-CRAMPING IN THE DOG, Circulation, 92(8), 1995, pp. 1065-1065
POTENT TRIAZOLINONE-BASED ANGIOTENSIN-II RECEPTOR ANTAGONISTS WITH EQUIVALENT AFFINITY FOR BOTH THE AT(1) AND AT(2) SUBTYPES
Authors: CHANG LL ASHTON WT FLANAGAN KL RIVERO RA CHEN TB OMALLEY SS ZINGARO GJ KIVLIGHN SD SIEGL PKS LOTTI VJ CHANG RSL GREENLEE WJ
Citation: Ll. Chang et al., POTENT TRIAZOLINONE-BASED ANGIOTENSIN-II RECEPTOR ANTAGONISTS WITH EQUIVALENT AFFINITY FOR BOTH THE AT(1) AND AT(2) SUBTYPES, Bioorganic & medicinal chemistry letters, 4(23), 1994, pp. 2787-2792
DEVELOPMENT OF ANGIOTENSIN-II ANTAGONISTS WITH EQUIPOTENT AFFINITY FOR HUMAN AT(1) AND AT(2) RECEPTOR SUBTYPES
Authors: GLINKA TW DELASZLO SE SIEGL PKS CHANG RS KIVLIGHN SD SCHORN TS FAUST KA CHEN TB ZINGARO GJ LOTTI VJ GREENLEE WJ
Citation: Tw. Glinka et al., DEVELOPMENT OF ANGIOTENSIN-II ANTAGONISTS WITH EQUIPOTENT AFFINITY FOR HUMAN AT(1) AND AT(2) RECEPTOR SUBTYPES, Bioorganic & medicinal chemistry letters, 4(19), 1994, pp. 2337-2342
Risultati: 1-25 | 26-47